Current Status and Perspectives of Therapeutic Antibodies Targeting the Spike Protein S2 Subunit against SARS-CoV-2

Evaluating therapeutic potential of AYUSH-64 constituents against omicron variant of SARS-CoV-2 using ensemble docking and simulations

“…Several therapeutic and preventive approaches have gained impetus since the onset of this infectious disease. Small molecules, monoclonal antibodies, nanodrugs and ayurvedic medicine have been explored extensively to identify their potential as treatment against COVID-19 ( Cha-Silva et al, 2024 ; Allerton et al, 2024 ; Yamamoto and Inoue, 2024 ; Tang et al, 2020 ; Medhi et al, 2020 ; H Ali et al, 2022 ).…”